Compounds and methods for treating dyslipidemia

Details for Australian Patent Application No. 2005230915 (hide)

Owner Eli Lilly and Company

Inventors Martin De La Nava, Eva Maria; Cao, Guoqing; Fernandez, Maria Carmen; Wang, Xiaodong; Mayhugh, Daniel Ray; Mateo Herranz, Ana Isabel; Bell, Michael Gregory; Lander, Peter Ambrose; Mantlo, Nathan Bryan; Escribano, Ana Maria

Agent Spruson & Ferguson

Pub. Number AU-A-2005230915

PCT Pub. Number WO2005/097806

Priority 60/557,134 26.03.04 US; 60/621,162 22.10.04 US

Filing date 17 March 2005

Wipo publication date 20 October 2005

International Classifications

C07D 495/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms

A61K 31/435 (2006.01) - having six-membered rings with one nitrogen as the only ring hetero atom

A61K 31/44 (2006.01) - Non-condensed pyridines

A61K 31/47 (2006.01) - Quinolines

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

C07D 221/00 (2006.01) Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups

C07D 333/00 (2006.01) Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

Event Publications

31 August 2006 PCT application entered the National Phase

  PCT publication WO2005/097806 Priority application(s): WO2005/097806

9 April 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005230916-Protein expression yield enhancement in cell-free protein synthesis systems by addition of antifoam agents

2005230907-Optimized expression of HPV 52 L1 in yeast